Premier Fund Managers Ltd grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 20.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 120,049 shares of the healthcare conglomerate’s stock after buying an additional 20,049 shares during the quarter. UnitedHealth Group accounts for approximately 2.3% of Premier Fund Managers Ltd’s holdings, making the stock its 11th biggest holding. Premier Fund Managers Ltd’s holdings in UnitedHealth Group were worth $61,898,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Financial Management Professionals Inc. lifted its position in shares of UnitedHealth Group by 0.8% during the first quarter. Financial Management Professionals Inc. now owns 2,224 shares of the healthcare conglomerate’s stock worth $1,165,000 after purchasing an additional 17 shares during the last quarter. Global Wealth Strategies & Associates boosted its position in UnitedHealth Group by 28.6% in the 1st quarter. Global Wealth Strategies & Associates now owns 90 shares of the healthcare conglomerate’s stock valued at $47,000 after buying an additional 20 shares during the period. Kolinsky Wealth Management LLC raised its stake in shares of UnitedHealth Group by 1.0% during the fourth quarter. Kolinsky Wealth Management LLC now owns 2,135 shares of the healthcare conglomerate’s stock valued at $1,080,000 after acquiring an additional 21 shares in the last quarter. Retirement Planning Group LLC lifted its holdings in shares of UnitedHealth Group by 5.1% in the 1st quarter. Retirement Planning Group LLC now owns 430 shares of the healthcare conglomerate’s stock worth $225,000 after buying an additional 21 shares during the period. Finally, Net Worth Advisory Group raised its holdings in shares of UnitedHealth Group by 0.6% in the first quarter. Net Worth Advisory Group now owns 3,642 shares of the healthcare conglomerate’s stock valued at $1,907,000 after acquiring an additional 21 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.
Analysts Set New Price Targets
UNH has been the subject of several recent research reports. UBS Group restated a “buy” rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Truist Financial dropped their target price on UnitedHealth Group from $360.00 to $345.00 and set a “buy” rating on the stock in a research report on Wednesday, July 16th. TD Securities restated a “hold” rating and set a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Baird R W downgraded shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, June 11th. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a “buy” rating on the stock in a research report on Wednesday, May 14th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $392.29.
Insiders Place Their Bets
In related news, Director Timothy Patrick Flynn purchased 1,533 shares of the firm’s stock in a transaction on Wednesday, May 14th. The stock was bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the completion of the acquisition, the director owned 6,033 shares of the company’s stock, valued at $1,935,386.40. The trade was a 34.07% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Kristen Gil acquired 3,700 shares of the company’s stock in a transaction dated Thursday, May 15th. The shares were purchased at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director directly owned 3,818 shares in the company, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders have acquired 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is currently owned by company insiders.
UnitedHealth Group Stock Performance
Shares of NYSE UNH opened at $282.13 on Tuesday. The stock has a market cap of $255.93 billion, a price-to-earnings ratio of 11.81, a PEG ratio of 1.39 and a beta of 0.45. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a 50 day simple moving average of $300.91 and a two-hundred day simple moving average of $422.56. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.
UnitedHealth Group Increases Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were given a dividend of $2.21 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 3.13%. The ex-dividend date of this dividend was Monday, June 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 37.02%.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Read More
- Five stocks we like better than UnitedHealth Group
- What Are Growth Stocks and Investing in Them
- Why the American Eagle Stock Rally Isn’t Just Speculation
- Utilities Stocks Explained – How and Why to Invest in Utilities
- D-Wave, SuperQ, and Verge: A New Path Forward for Quantum?
- Canada Bond Market Holiday: How to Invest and Trade
- 4 Stocks Planning to Substantially Boost Buybacks After Solid Q2
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.